IGFBP-2 directly stimulates osteoblast differentiation

Journal of Bone and Mineral Research

Volumn 29, Issue 11, 2014, Pages 2427-2438

  Xi, Gang ^a   Wai, Christine ^a   DeMambro, Victoria ^b   Rosen, Clifford J ^b   Clemmons, David R ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b Maine Medical Center Research Institute   (United States)

Author keywords

IGFBP 2; osteoblast differentiation; pAKT; PTEN; RPTP

Indexed keywords

OSTEOCALCIN; OSTEOPONTIN; PROTEIN KINASE B; PROTEIN TYROSINE PHOSPHATASE; RECEPTOR TYROSINE PHOSPHATASE BETA; SOMATOMEDIN BINDING PROTEIN 2; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; RECEPTOR LIKE PROTEIN TYROSINE PHOSPHATASE;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BONE MASS; CELL DIFFERENTIATION; CELL PROLIFERATION; COMPLEX FORMATION; CONTROLLED STUDY; DNA SEQUENCE; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE OVEREXPRESSION; MOUSE; NONHUMAN; OSTEOBLAST; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; TISSUE DIFFERENTIATION; ANIMAL; BIOSYNTHESIS; CELL LINE; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; GENE EXPRESSION REGULATION; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; MICE; MICE, KNOCKOUT; OSTEOBLASTS; OSTEOCALCIN; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 5;

EID: 84923784403     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2282     Document Type: Article

References (36)

1. Firth SM, Baxter RC., Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev. 2002; 23 (6): 824-54.
2. Palermo C, Manduca P, Gazzerro E, Foppiani L, Segat D, Barreca A., Potentiating role of IGFBP-2 on IGF-II-stimulated alkaline phosphatase activity in differentiating osteoblasts. Am J Physiol Endocrinol Metab. 2004; 286 (4): E648-57.
3. DeMambro VE, Clemmons DR, Horton LG, et al., Gender-specific changes in bone turnover and skeletal architecture in igfbp-2-null mice. Endocrinology. 2008; 149 (5): 2051-61.
4. Kawai M, Breggia AC, DeMambro VE, et al., The heparin-binding domain of IGFBP-2 has insulin-like growth factor binding-independent biologic activity in the growing skeleton. J Biol Chem. 2011; 286 (16): 14670-80.
5. Govoni KE, Lee SK, Chung YS, et al., Disruption of insulin-like growth factor-I expression in type IIalphaI collagen-expressing cells reduces bone length and width in mice. Physiol Genomics. 2007; 30 (3): 354-62.
6. Kawase T, Okuda K, Kogami H, et al., Characterization of human cultured periosteal sheets expressing bone-forming potential: in vitro and in vivo animal studies. J Tissue Eng Regen Med. 2009; 3 (3): 218-29.
7. Lee JH, Hwang KJ, Kim MY, et al., Human parathyroid hormone increases the mRNA expression of the IGF system and hematopoietic growth factors in osteoblasts, but does not influence expression in mesenchymal stem cells. J Pediatr Hematol Oncol. 2012; 34 (7): 491-6.
8. Hamidouche Z, Fromigue O, Ringe J, Haupl T, Marie PJ., Crosstalks between integrin alpha 5 and IGF2/IGFBP2 signalling trigger human bone marrow-derived mesenchymal stromal osteogenic differentiation. BMC Cell Biol. 2010; 11: 44.
9. Shen X, Xi G, Maile LA, Wai C, Rosen CJ, Clemmons DR,. Insulin-like growth factor (IGF) binding protein 2 functions coordinately with receptor protein tyrosine phosphatase beta and the IGF-I receptor to regulate IGF-I-stimulated signaling. Mol Cell Biol. 2012; 32 (20): 4116-30.
10. Xian L, Wu X, Pang L, et al., Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells. Nat Med. 2012; 18 (7): 1095-101.
11. Cohick WS, Clemmons DR,. Regulation of insulin-like growth factor binding protein synthesis and secretion in a bovine epithelial cell line. Endocrinology. 1991; 129 (3): 1347-54.
12. Xi G, Shen X, Clemmons DR,. p66shc negatively regulates insulin-like growth factor I signal transduction via inhibition of p52shc binding to Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 leading to impaired growth factor receptor-bound protein-2 membrane recruitment. Mol Endocrinol. 2008; 22 (9): 2162-75.
13. Wang D, Christensen K, Chawla K, Xiao G, Krebsbach PH, Franceschi RT., Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential. J Bone Miner Res. 1999; 14 (6): 893-903.
14. Raucci A, Bellosta P, Grassi R, Basilico C, Mansukhani A., Osteoblast proliferation or differentiation is regulated by relative strengths of opposing signaling pathways. J Cell Physiol. 2008; 215 (2): 442-51.
15. Schinke T, Gebauer M, Schilling AF, et al., The protein tyrosine phosphatase Rptpzeta is expressed in differentiated osteoblasts and affects bone formation in mice. Bone. 2008; 42 (3): 524-34.
16. Conover CA, Johnstone EW, Turner RT, et al., Subcutaneous administration of insulin-like growth factor (IGF)-II/IGF binding protein-2 complex stimulates bone formation and prevents loss of bone mineral density in a rat model of disuse osteoporosis. Growth Horm IGF Res. 2002; 12 (3): 178-83.
17. Kiepe D, Van Der Pas A, Ciarmatori S, et al., Defined carboxy-terminal fragments of insulin-like growth factor (IGF) binding protein-2 exert similar mitogenic activity on cultured rat growth plate chondrocytes as IGF-I. Endocrinology. 2008; 149 (10): 4901-11.
18. Higuchi C, Myoui A, Hashimoto N, et al., Continuous inhibition of MAPK signaling promotes the early osteoblastic differentiation and mineralization of the extracellular matrix. J Bone Miner Res. 2002; 17 (10): 1785-94.
19. Nakayama K, Tamura Y, Suzawa M, et al., Receptor tyrosine kinases inhibit bone morphogenetic protein-Smad responsive promoter activity and differentiation of murine MC3T3-E1 osteoblast-like cells. J Bone Miner Res. 2003; 18 (5): 827-35.
20. Viereck V, Siggelkow H, Pannem R, Braulke T, Scharf JG, Kubler B., Alteration of the insulin-like growth factor axis during in vitro differentiation of the human osteosarcoma cell line HOS 58. J Cell Biochem. 2007; 102 (1): 28-40.
21. Thrailkill KM, Siddhanti SR, Fowlkes JL, Quarles LD., Differentiation of MC3T3-E1 osteoblasts is associated with temporal changes in the expression of IGF-I and IGFBPs. Bone. 1995; 17 (3): 307-13.
22. Hakeda Y, Yoshizawa K, Hurley M, et al., Stimulatory effect of a phorbol ester on expression of insulin-like growth factor (IGF) binding protein-2 and level of IGF-I receptors in mouse osteoblastic MC3T3-E1 cells. J Cell Physiol. 1994; 158 (3): 444-50.
23. Hurley MM, Abreu C, Hakeda Y., Basic fibroblast growth factor regulates IGF-I binding proteins in the clonal osteoblastic cell line MC3T3-E1. J Bone Miner Res. 1995; 10 (2): 222-30.
24. Yerges LM, Klei L, Cauley JA, et al., Candidate gene analysis of femoral neck trabecular and cortical volumetric bone mineral density in older men. J Bone Miner Res. 2010; 25 (2): 330-8.
25. Huynh H, Zheng J, Umikawa M, et al., IGF binding protein 2 supports the survival and cycling of hematopoietic stem cells. Blood. 2011; 118 (12): 3236-43.
26. Celebi B, Mantovani D, Pineault N., Insulin-like growth factor binding protein-2 and neurotrophin 3 synergize together to promote the expansion of hematopoietic cells ex vivo. Cytokine. 2012; 58 (3): 327-31.
27. Wood AW, Schlueter PJ, Duan C., Targeted knockdown of insulin-like growth factor binding protein-2 disrupts cardiovascular development in zebrafish embryos. Mol Endocrinol. 2005; 19 (4): 1024-34.
28. DeMambro VE, Maile L, Wai C, et al., Insulin-like growth factor-binding protein-2 is required for osteoclast differentiation. J Bone Miner Res. 2012; 27 (2): 390-400.
29. Sharples AP, Al-Shanti N, Hughes DC, Lewis MP, Stewart CE., The role of insulin-like-growth factor binding protein 2 (IGFBP2) and phosphatase and tensin homologue (PTEN) in the regulation of myoblast differentiation and hypertrophy. Growth Horm IGF Res. 2013; 23 (3): 53-61.
30. Mukherjee A, Rotwein P., Akt promotes BMP2-mediated osteoblast differentiation and bone development. J Cell Sci. 2009; 122 (Pt 5): 716-26.
31. Yeh LC, Ma X, Matheny RW, Adamo ML, Lee JC., Protein kinase D mediates the synergistic effects of BMP-7 and IGF-I on osteoblastic cell differentiation. Growth Factors. 2010; 28 (5): 318-28.
32. Longobardi L, Granero-Molto F, O'Rear L, et al., Subcellular localization of IRS-1 in IGF-I-mediated chondrogenic proliferation, differentiation and hypertrophy of bone marrow mesenchymal stem cells. Growth Factors. 2009; 27 (5): 309-20.
33. Chen L, Jiang W, Huang J, et al., Insulin-like growth factor 2 (IGF-2) potentiates BMP-9-induced osteogenic differentiation and bone formation. J Bone Miner Res. 2010; 25 (11): 2447-59.
34. Zhao G, Monier-Faugere MC, Langub MC, et al., Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation. Endocrinology. 2000; 141 (7): 2674-82.
35. Zhang M, Xuan S, Bouxsein ML, et al., Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization. J Biol Chem. 2002; 277 (46): 44005-12.
36. Kesavan C, Wergedal JE, Lau KH, Mohan S., Conditional disruption of IGF-I gene in type 1alpha collagen-expressing cells shows an essential role of IGF-I in skeletal anabolic response to loading. Am J Physiol Endocrinol Metab. 2011; 301 (6): E1191-7.